Cutting Edge Laser Technologies: Innovative Laser Therapy for Orthopedics
Harold Kenrick, CEO
In the current era of healthcare reform, declining reimbursements are the greatest financial challenge in the face of physicians trying to grow their businesses. As an increasing number of healthcare groups adopt bundled payment programs to realize healthcare cost savings, diligence in providing the best results for patients becomes a necessity. Observing over 500,000 deaths from opioid overdose since 2001, many states mandate surgeons to explore beyond the boundaries of surgeries and drugs and offer alternatives for pain relief. In fact, in orthopedics, 85 percent of patients encountered by surgeons on a day-to-day basis have conditions that can be remedied without surgery. MLS Laser Therapy is the answer.
To help the orthopedics space ease into this eventuality, New York-based Cutting Edge Laser Technologies offers its laser innovation, the Multiwave Locked System (MLS) Laser Therapy, a new approach to pain management. Over a 100 million Americans have back pain, and another 45 percent of the population predicted to have osteoarthritis down the road. The team at Cutting Edge believes they can solve the issue of chronic pain management that’s crippling the U.S. population.
Orthopedic surgeons can help their existing patients and attract new ones by providing treatments with less pain and faster recovery times with this non-pharmacological and non-surgical solution to pain. “Our motto is ‘Better Medicine = Better Business’, and we’re here to help,” says Harold Kenrick, CEO, Cutting Edge Laser Technologies.
There are over 25,000 MLS units worldwide in 90 countries treating 15 million patients per year. MLS is the only patented Class- IV laser in the world that doesn’t generate heat. This is important for the orthopedic surgeon because they can use it over screws, plates, and hardware without denaturing the DNA or creating any thermal damage.
The MLS fires two lasers up to four to five centimeters penetration, both simultaneous and synchronized—this is our secret sauce
“The MLS fires two lasers, firing both simultaneous and synchronized and penetrating 4-5 centimeters deep— this is our secret sauce,” says Kenrick.
The mechanisms of the product during the therapy involves blocking pain signals to the brain and extracting all toxins like histamine and cytokine out of the cells allowing more oxygen and food loads to enter. Stimulating the mitochondria, the energy in the cells, leads to ATP (Adenosine triphosphate) production, which is actually cell growth.
Kenrick recalls a particular incident wherein a nurse who had invested $30,000 on a custom knee for getting a total knee replacement, came for a consultation with Cutting Edge. “We treated her over a three week period, and that was three years ago. To this day, she never had to get that knee replaced,” says Kenrick.
Totally pre-programmed and easy to use, the robotic MLS is the only unattended laser in the world that frees up the staff members to help with new patients. The company makes a concerted effort to provide awareness of their product and explain their value propositions to orthopedic surgeons as alternatives to both surgeries and drugs. “With over 200 years of marketing and sales experience, we ensure the physicians’ success by providing all the marketing they need,” says Kenrick.
Orthopedic executives tasked with growing revenues for their practices will find MLS Laser Therapy is the “Perfect” Cash base modality to add to their practice. Many practices have added multiple units to their various offices because of their initial success.
“While we’re working on an orthopedics-specific platform, we intend to foray into more verticals as part of our plans for future growth,” says Kenrick. Providing a win-win solution for both the patients and the surgeons provides a promising future for Cutting Edge.
This content is copyright protected
However, if you would like to share the information in this article, you may use the link below: